US Stock MarketDetailed Quotes

XCUR Exicure

Watchlist
  • 0.6015
  • -0.0161-2.61%
Close Mar 28 16:00 ET
  • 0.6101
  • +0.0086+1.43%
Post 18:03 ET
5.20MMarket Cap0.34P/E (TTM)

About Exicure Company

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.

Company Profile

SymbolXCUR
Company NameExicure
Listing Date07/31/2019
Founded2011
CEOMr. Paul Kang
MarketNASDAQ
Employees13
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2430 North Halsted Street
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60614
Phone1-847-673-1700

Company Executives

  • Name
  • Position
  • Salary
  • Paul Kang
  • Director, Chief Executive Officer and President
  • --
  • Jiyoung Hwang
  • Director, Chief Financial Officer and Secretary
  • --
  • Joshua Miller
  • Chief Accounting Officer
  • --
  • Hyuk Joon Ko
  • Director
  • --
  • Dongho Lee
  • Director
  • --
  • Hojoon Lee
  • Director
  • --
  • Minhee Eom
  • Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg